Aurora Diagnostics acquires CytoPath
Dragonimages / iStock
HealthCombix, a global decentralized healthcare development company, has appointed Matthew Conboy to its healthcare blockchain advisory board.
Conboy is a healthcare professional with a background in strategy, risk assurance, and technology. He began his career as a healthcare and financial services consultant at PricewaterhouseCoopers (PwC), serving clients in healthcare and life and disability insurance.
Conboy is currently a director of innovation at CareAllies, a Cigna company, and leads solution development for CareAllies's home-based chronic care management division, Alegis Care. Prior to joining CareAllies, Conboy worked for Cigna's enterprise strategic operations team, helping business unit leaders translate enterprise-level strategy into operational plans. In addition, Conboy co-founded Cigna's internal blockchain team, which assesses blockchain-specific opportunities in alignment with Cigna's strategy.
"HealthCombix is excited to have Mathew as an adviser. Mathew brings an enterprise, risk management, and population health perspective to the team and project. We look forward to collaborating on envisioning next generation open healthcare ecosystems and networks," said Cyrus Maaghul, CEO of HealthCombix.
HealthCombix combines confidential human data asset management, disease and wellness prediction markets, and the power of open, decentralized payment networks to build future healthcare ecosystems, DAOs, and cooperatives.
PwC, PricewaterhouseCoopers, HealthCombix, blockchain, Appointment, Matthew Conboy, Cyrus Maaghul, US